SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): July 28, 2003
INVITROGEN CORPORATION
Delaware | 0-25317 | 33-0373077 | ||
(State or other jurisdiction of incorporation) |
(Commission File No.) | (IRS Employer Identification No.) |
1600 Faraday Avenue, Carlsbad, CA | 92008 | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (760) 603-7200
Not Applicable
Item 5. OTHER EVENTS | ||||||||
Item 7. FINANCIAL STATEMENTS AND EXHIBITS. | ||||||||
SIGNATURE | ||||||||
EXHIBIT INDEX | ||||||||
EXHIBIT 99.1 | ||||||||
EXHIBIT 99.2 |
Item 5. OTHER EVENTS
On July 28, 2003, Invitrogen Corporation (the Company) issued two press releases regarding its offering of $325 million aggregate principal amount of 2% Convertible Senior Notes due 2023 plus a 13 day over-allotment option to purchase up to an additional $48.25 million of 2% Convertible Senior Notes to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Attached as Exhibits 99.1 and 99.2 are press releases of the Company regarding the offering of the Convertible Senior Notes. Exhibits 99.1 and 99.2 are incorporated by reference under this Item 5.
Item 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
Exhibit | Description | |
99.1 | Invitrogen Corporation press release dated July 28, 2003 regarding the offering of convertible senior notes. | |
99.2 | Invitrogen Corporation press release dated July 28, 2003 regarding the offering of convertible senior notes. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Invitrogen Corporation | ||||
Date: July 29, 2003 | By: | /s/ C. Eric Winzer
C. Eric Winzer Chief Financial Officer |
EXHIBIT INDEX
Exhibit | Description | |
99.1 | Invitrogen Corporation press release dated July 28, 2003 regarding the offering of convertible senior notes. | |
99.2 | Invitrogen Corporation press release dated July 28, 2003 regarding the offering of convertible senior notes. |